Jeff Soinski
About Jeff Soinski
Jeffrey M. Soinski is an experienced executive who has led several healthcare and medical technology companies, including roles as CEO of Medical Imaging Holdings and Specialized Health Products International.
Jeffrey M. Soinski - CEO Career Overview
Jeffrey M. Soinski has held several significant leadership roles throughout his career. Currently, he serves as the Chief Executive Officer. His experience includes serving as the CEO of Medical Imaging Holdings and Unisyn Medical Technologies from its inception in September 2009 until the acquisition of Unisyn by GE Healthcare in May 2013. He also played a leading role at Specialized Health Products International, where he was the President and CEO from 2001 until its acquisition by C.R. Bard in 2008.
Jeffrey M. Soinski's Education
Jeffrey M. Soinski holds a Bachelor of Arts degree from Dartmouth College. This academic background has provided a robust foundation for his subsequent career in various executive roles within the healthcare and medical technology industries.
Leadership at Medical Imaging Holdings and Unisyn Medical Technologies
Jeffrey M. Soinski served as the Chief Executive Officer of Medical Imaging Holdings and Unisyn Medical Technologies from September 2009 until May 2013, when GE Healthcare acquired Unisyn. During his tenure, he was instrumental in the formation and growth of these companies. He continued to serve as a director of Medical Imaging Holdings and Consensys Imaging Service until its acquisition in October 2017.
Jeffrey M. Soinski's Role at Galen Partners
Jeffrey M. Soinski has been associated with Galen Partners, a leading healthcare-focused private equity firm, as a Special Venture Partner from July 2008 to June 2013. Since October 2016, he has served as a Special Investment Partner for Galen Partners, contributing his expertise to the firm's healthcare investments.
Earlier Career - ViroTex Corporation
Earlier in his career, Jeffrey M. Soinski was the President and CEO of ViroTex Corporation, a pharmaceutical drug delivery company backed by venture capital. He successfully led the company until its sale to Atrix Laboratories in 1998, demonstrating his capability in managing and scaling innovative healthcare enterprises.
Board Membership at Merriman Holdings
Jeffrey M. Soinski served on the board of directors of Merriman Holdings, the parent company of Merriman Capital, a San Francisco-based investment banking and brokerage firm. His tenure on the board lasted from 2008 until March 2016, during which he contributed to the governance and strategic direction of the firm.